Literature DB >> 22912353

Submitting the entire gallbladder in cases of dysplasia is not justified.

Andrew A Renshaw1, Edwin W Gould.   

Abstract

When dysplasia is identified in a gallbladder, many experts recommend submission of the entire gallbladder for histologic examination. We sought to determine if this practice could be justified. We reviewed 16,611 gallbladder resections over an 8-year period, and identified 17 cases of carcinoma (15 primary and 2 metastatic), 9 cases of high-grade dysplasia, 16 cases of low-grade dysplasia, and 81 cases with atypia, not otherwise specified (NOS). Sixteen (94%) of 17 adenocarcinomas were identified and sampled on the initial gross inspection, and the remaining case was identified and sampled on review of the gross specimen. None of the high- or low-grade dysplasias were identified on gross examination, but all were identified as atypical on the initial slide submitted and correctly graded with the submission of 4 additional slides. Eight (89%) of 9 high-grade, 6 (38%) of 16 low-grade, and 1 (1%) of 81 atypia, NOS, cases were subsequently entirely submitted without identification of any new lesion. We conclude that for cases of dysplasia and atypia, NOS, review of the gross specimen and submission of up to 4 additional sections identify all significant lesions, and submission of the entire gallbladder is not justified.

Entities:  

Mesh:

Year:  2012        PMID: 22912353     DOI: 10.1309/AJCPB0ZTXXIF6MOF

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  5 in total

1.  Dysplasia in Gallbladder: What Should We Do?

Authors:  Rehan Rais; Iván González; Deyali Chatterjee
Journal:  J Gastrointest Surg       Date:  2018-09-13       Impact factor: 3.452

2.  Gallbladder cancer: expert consensus statement.

Authors:  Thomas A Aloia; Nicolas Járufe; Milind Javle; Shishir K Maithel; Juan C Roa; Volkan Adsay; Felipe J F Coimbra; William R Jarnagin
Journal:  HPB (Oxford)       Date:  2015-08       Impact factor: 3.647

3.  T2 gallbladder cancer shows substantial survival variation between continents and this is not due to histopathologic criteria or pathologic sampling differences.

Authors:  Mia S DeSimone; Michael Goodman; Burcin Pehlivanoglu; Bahar Memis; Serdar Balci; Juan Carlos Roa; Kee-Taek Jang; Jin-Young Jang; Seung-Mo Hong; Kyoungbun Lee; Haeryoung Kim; Hye-Jeong Choi; Takashi Muraki; Juan Carlos Araya; Enrique Bellolio; Juan M Sarmiento; Shishir K Maithel; Hector F Losada; Olca Basturk; Michelle D Reid; Jill Koshiol; Volkan Adsay
Journal:  Virchows Arch       Date:  2021-01-07       Impact factor: 4.064

4.  Incidental Gallbladder Cancer on Cholecystectomy: Strategy for Re-resection of Presumed Benign Diseases from a Retrospective Multicenter Study by the Yokohama Clinical Oncology Group.

Authors:  Ryusei Matsuyama; Kenichi Matsuo; Ryutaro Mori; Mitsutaka Sugita; Naotaka Yamaguchi; Toru Kubota; Kunio Kameda; Yasuhisa Mochizuki; Ryo Takagawa; Toshiaki Kadokura; Goro Matsuda; Noriyuki Kamiya; Itaru Endo
Journal:  In Vivo       Date:  2021 Mar-Apr       Impact factor: 2.155

5.  Impact of Type of Surgery on Survival Outcome in Patients With Early Gallbladder Cancer in the Era of Minimally Invasive Surgery: Oncologic Safety of Laparoscopic Surgery.

Authors:  Jin-Young Jang; Jin Seok Heo; Youngmin Han; Jihoon Chang; Jae Ri Kim; Hongbeom Kim; Wooil Kwon; Sun-Whe Kim; Seong Ho Choi; Dong Wook Choi; Kyoungbun Lee; Kee-Taek Jang; Sung-Sik Han; Sang-Jae Park
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.